JFC1, also known as Synaptotagmin-Like Protein 1 (SYTL1), is a gene that encodes a protein involved in the regulation of membrane trafficking and exocytosis. The JFC1 protein is a member of the synaptotagmin-like protein family, which is characterized by the presence of C2 domains. These C2 domains are known to bind phospholipids and are critical for the protein's function in vesicular trafficking.JFC1 plays a significant role in the regulation of vesicle exocytosis, particularly in the context of the release of neurotransmitters and other signaling molecules. It is involved in the process of docking and fusion of vesicles with the plasma membrane, a key step in the exocytosis pathway. This process is essential for the communication between neurons in the nervous system, as well as for the release of hormones and other mediators in various tissues.
The protein is also implicated in the formation of the immunological synapse, an important feature in the adaptive immune response. It helps in the transport of vesicles containing signaling molecules to the immunological synapse, thereby influencing immune cell activation and response.Alterations in the expression or function of JFC1 can have implications in various neurological and immunological disorders. Given its role in neurotransmitter release, JFC1 is a subject of interest in the study of neurological diseases that involve dysregulated neurotransmission, such as epilepsy and schizophrenia.
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates adenylate cyclase, leading to increased cAMP levels, which can influence signaling pathways related to JFC1. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC), which is involved in multiple signaling pathways that could intersect with JFC1 functions. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin increases intracellular calcium levels, potentially affecting calcium-dependent processes linked with JFC1. | ||||||
Insulin | 11061-68-0 | sc-29062 sc-29062A sc-29062B | 100 mg 1 g 10 g | $156.00 $1248.00 $12508.00 | 82 | |
Insulin activates the insulin signaling pathway, potentially influencing JFC1-related cellular functions. | ||||||
Adenosine 3′,5′-cyclic monophosphate | 60-92-4 | sc-217584 sc-217584A sc-217584B sc-217584C sc-217584D sc-217584E | 100 mg 250 mg 5 g 10 g 25 g 50 g | $116.00 $179.00 $265.00 $369.00 $629.00 $1150.00 | ||
cAMP, as a secondary messenger, can modulate various signaling pathways that may indirectly influence JFC1 activity. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Okadaic Acid inhibits protein phosphatases, affecting phosphorylation states of proteins that could interact with JFC1. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin disrupts calcium homeostasis, potentially affecting JFC1-related calcium-dependent processes. | ||||||
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $31.00 $53.00 $124.00 $374.00 | 25 | |
Brefeldin A disrupts Golgi apparatus function, which could indirectly affect JFC1's role in membrane trafficking. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin inhibits PI3K, potentially influencing pathways that intersect with JFC1 activity. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin inhibits mTOR, which can affect various cellular processes and signaling pathways relevant to JFC1. | ||||||